Post Market Clinical Follow-Up Study on the Performance and Safety of Lyoplant® (LYOPLACE)

Aesculap

Status: Completed

Conditions: Tumor, Cerebral Ventricle; Aneurysm Cerebral; Trauma, Brain; Tumor, Cerebellar

Treatments: Device: Lyoplant®

Study type: Observational

Funder types: Industry

Identifiers

NCT05441618

AAG-O-H-2112

Details and patient eligibility

About

Retrospective, single center, single arm PMCF study on the performance and safety of Lyoplant® used for the replacement and extension of connective tissue structures in neurosurgery.

Enrollment: 50 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age ≥ 18 years
• Use of investigational device according to Instructions for Use (IfU)

Exclusion criteria

• none

Trial design

50 participants in 1 patient group

Lyoplant®

Description:

Lyoplant® is a pure collagen implant obtained from bovine pericardium. The membrane is used for the replacement and extension of connective tissue structures in neurosurgery.

Treatment:

Device: Lyoplant®